Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David F. Condon"'
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 1, Pp 9-22 (2019)
Abstract The past 20 years have seen major advances in the diagnosis and management of pulmonary hypertension, a disease associated with significant morbidity and mortality. The 6th World Symposium in Pulmonary Hypertension (WSPH) took place in Febru
Externí odkaz:
https://doaj.org/article/4c1f7207334f43ad944cf7b49a1af572
Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension
Autor:
Shaun Pienkos, Natalia Gallego, David F. Condon, Alejandro Cruz-Utrilla, Nuria Ochoa, Julián Nevado, Pedro Arias, Stuti Agarwal, Hiral Patel, Ananya Chakraborty, Pablo Lapunzina, Pilar Escribano, Jair Tenorio-Castaño, Vinicio A. de Jesús Pérez
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling and right heart failure. Specific genetic variants increase the incidence of PAH in carriers with a family history of PAH, those who su
Externí odkaz:
https://doaj.org/article/637074f2978f4a11bb2e824311ae33e9
Autor:
Nils P. Nickel, Elya A. Shamskhou, Moataz A. Razeen, David F. Condon, Louise A. Messentier Louro, Alfredo Dubra, Yaping J. Liao, Roham T. Zamanian, Ke Yuan, Vinicio A. de Jesus Perez
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/b37eba8cc03b4fa89f83a26b54ac9466
Autor:
Ananya Chakraborty, Abinaya Nathan, Mark Orcholski, Stuti Agarwal, Elya A. Shamskhou, Natasha Auer, Ankita Mitra, Eleana Stephanie Guardado, Gowri Swaminathan, David F. Condon, Joyce Yu, Matthew McCarra, Nicholas H. Juul, Alden Mallory, Roberto A. Guzman-Hernandez, Ke Yuan, Vanesa Rojas, Joseph T. Crossno, Lai-Ming Yung, Paul B. Yu, Thomas Spencer, Robert A. Winn, Andrea Frump, Vijaya Karoor, Tim Lahm, Haley Hedlin, Jeffrey R. Fineman, Robert Lafyatis, Carsten N. F. Knutsen, Cristina M. Alvira, David N. Cornfield, Vinicio A. de Jesus Perez
Publikováno v:
European Respiratory Journal. :2201625
IntroductionPulmonary arterial hypertension (PAH) is characterized by loss of microvessels. The Wnt pathways control pulmonary angiogenesis, but their role in PAH is incompletely understood. We hypothesized that Wnt activation in pulmonary microvascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3e8bc719814c03d20616a6c7d3c2bcf
https://doi.org/10.1183/13993003.01625-2022
https://doi.org/10.1183/13993003.01625-2022
Autor:
Shaun, Pienkos, Natalia, Gallego, David F, Condon, Alejandro, Cruz-Utrilla, Nuria, Ochoa, Julián, Nevado, Pedro, Arias, Stuti, Agarwal, Hiral, Patel, Ananya, Chakraborty, Pablo, Lapunzina, Pilar, Escribano, Jair, Tenorio-Castaño, Vinicio A, de Jesús Pérez
Publikováno v:
Frontiers in Medicine
Background: Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling and right heart failure. Specific genetic variants increase the incidence of PAH in carriers with a family history of PAH, those who su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4998316b0780a1ee354808780f579249
https://pubmed.ncbi.nlm.nih.gov/33996849
https://pubmed.ncbi.nlm.nih.gov/33996849
Publikováno v:
F1000Research, Vol 8 (2019)
In February 2018, the 6th World Symposium on Pulmonary Hypertension (WSPH) brought together experts from various disciplines to review the most relevant clinical and scientific advances in the field of PH over the last 5 years. Based on careful revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::7045820330c142328cd7c05ddb120349
https://f1000research.com/articles/8-888/v1
https://f1000research.com/articles/8-888/v1